Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes

Diabetologia

Volumn 49, Issue 10, 2006, Pages 2488-2498

  Yu, Y ^a   Thorpe, S R ^b   Jenkins, A J ^a   Shaw, J N ^b   Sochaski, M A ^b   McGee, D ^c   Aston, C E ^a   Orchard, T J ^d   Silvers, N ^d   Peng, Y G ^c   McKnight, J A ^e   Baynes, J W ^b   Lyons, T J ^a,c,f  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Collagen; Diabetes complications; Glycation; Methionine sulphoxide; Oxidative stress

Indexed keywords

6 N CARBOXYMETHYLLYSINE; COLLAGEN; FRUCTOSE; LYSINE; METHIONINE SULFOXIDE; PENTOSIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLYCATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN BIOPSY;

ADULT; AGED; BIOPSY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COLLAGEN; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METHIONINE; MIDDLE AGED; REFERENCE VALUES; SKIN; TRIGLYCERIDES;

EID: 33748478331     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0355-8     Document Type: Article

References (34)

1. Lyons TJ (2002) Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes. Semin Vasc Med 2:175-189
2. Thorpe SR, Lyons TJ, Baynes JW (2000) Glycation and glycoxidation in diabetic vascular disease. In: Keaney JF (ed) Oxidative stress and vascular disease. Kluwer, Norwell, pp 259-283
3. ε-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986
4. ε-carboxymethyllysine in Maillard-type reactions. Ann N Y Acad Sci 1043:59-62
5. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW (1991) Decrease in skin collagen glycation with improved glycaemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 87:1910-1915
6. Dyer DG, Dunn JA, Thorpe SR et al (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 9:2463-2469
7. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM (1992) Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41:1286-1292
8. Beisswenger PJ, Moore LL, Brinck-Johnsen T, Curphey TJ (1993) Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217
9. Beisswenger PJ, Moore LL, Curuphey TJ (1993) Relationship between glycaemic control and collagen-linked advanced glycation end products in type 1 diabetes. Diabetes Care 16:689-694
10. McCance DR, Dyer DG, Dunn JA et al (1993) Maillard reaction products and their relation to the complications of diabetes. J Clin Invest 9:2470-2478
11. Onorato JM, Thorpe SR, Baynes JW (1998) Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease. Ann N Y Acad Sci 854:277-290
12. Wells-Knecht MC, Lyons TJ, McCance DR, Thorpe SR, Baynes JW (1997) Age-dependent accumulation of ortho-tyrosine and methionine sulfoxide in human skin collagen is not increased in diabetes: evidence against a generalised increase in oxidative stress in diabetes. J Clin Invest 100:839-846
13. The Diabetes Care and Complications Trial (DCCT) (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
14. Epidemiology of Diabetes Interventions and Complications (EDIC) (1999) Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22:99-111
15. The Diabetes Control and Complications Trial (DCCT) Research Group (1995) The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. Arch Ophthalmol 113:36-51
16. Jenkins AJ, Lyons TJ, Zheng D et al (2003) Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care 26:810-818
17. ε-(carboxymethyl)-hydroxylysine in human skin collagen. Biochemistry 30:1205-1210
18. Dyer DG, Blackledge JA, Thorpe SR Baynes JW (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266:11654-11660
19. Sochaski MA, Jenkins AJ, Lyons TJ, Thorpe SR, Baynes JW (2001) Isotope dilution gas chromatography/mass spectrometry method for the determination of methionine sulfoxide in protein. Anal Chem 73:4662-4667
20. The Diabetes Care and Complications Trial (DCCT) (1987) Feasibility study. Diabetes Care 10:1-19
21. 1c as markers of diabetic complications. Diabetes 48:870-880
22. Genuth S, Sun W, Cleary P, et al (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in DCCT/EDIC participants with type 1 diabetes. Diabetes 54:3103-3111
23. Ahmed MU, Frye EB, Degenhardt TP, Thorpe SR, Baynes JW (1997) N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-670
24. Degenhardt TP, Thorpe SR, Baynes JW (1998) Chemical modification of proteins by methylglyoxal. Cell Mol Biol 44:1139-1145
25. Szwergold BS, Beisswenger PJ (2003) Enzymatic deglycation - a new paradigm or an epiphenomenon? Biochem Soc Trans 31:1428-1432
26. Hoshi T, Heinemann S (2001) Regulation of cell function by methionine oxidation and reduction. J Physiol 531:1-11
27. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycaemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369-30374
28. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H (2003) Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 64:1632-1642
29. Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J (1992) Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 19:330-340
30. Miyata T, van Ypersele de Strihou C, Ueda Y, et al (2002) Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 13:2478-2487
31. Akira K, Amano M, Okajima F, Hashimoto T, Oikawa S (2006) Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits. Biol Pharm Bull 29:75-81
32. Ng DS (2005) The role of statins in oxidative stress and cardiovascular disease. Curr Drug Targets Cardiovasc Haematol Disord 5:165-175
33. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
34. Pennathur S, Ido Y, Heller JI et al (2005) Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes. J Biol Chem 280:22706-22714